Thermo Fisher Scientific Inc
NYSE:TMO
Relative Value
The Relative Value of one TMO stock under the Base Case scenario is 631.92 USD. Compared to the current market price of 572.8 USD, Thermo Fisher Scientific Inc is Undervalued by 9%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
TMO Competitors Multiples
Thermo Fisher Scientific Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.5B USD | 5.2 | 36.9 | 22.8 | 33.4 | ||
US |
Danaher Corp
NYSE:DHR
|
182B USD | 4.2 | 22.6 | 16.4 | 20.2 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.9B USD | 2.8 | 30.9 | 16.8 | 25.9 | ||
US |
Agilent Technologies Inc
NYSE:A
|
40.4B USD | 6 | 32.7 | 26.1 | 31.4 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 15 | 64.8 | 34.2 | 49.2 | ||
CH |
Lonza Group AG
SIX:LONN
|
36.8B CHF | 5.5 | 56.3 | 19.3 | 28.4 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.6B USD | 7 | 33.7 | 23.6 | 26.2 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.4B USD | 8.9 | 44.4 | 30.4 | 36.3 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
24.6B USD | 3 | 40.2 | 17.1 | 26.7 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
18.7B EUR | 6.9 | 73.5 | 31.7 | 52 | ||
US |
Illumina Inc
NASDAQ:ILMN
|
19.6B USD | 4.3 | -16.9 | 56.2 | -263.3 |